Seers Technology Co., LTD. (KOSDAQ:458870)
South Korea · Delayed Price · Currency is KRW 134,000
+9,400 (7.54%)
Nov 20, 2025, 3:30 PM KST
KOSDAQ:458870 Revenue
Seers Technology Co., LTD. had revenue of 4.07B KRW in the quarter ending March 31, 2025, with 445.08% growth. This brings the company's revenue in the last twelve months to 11.42B, up 377.24% year-over-year. In the year 2024, Seers Technology Co., LTD. had annual revenue of 8.10B with 329.69% growth.
Revenue (ttm)
11.42B
Revenue Growth
+377.24%
P/S Ratio
138.18
Revenue / Employee
335.92M
Employees
34
Market Cap
1.58T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.10B | 6.21B | 329.69% |
| Dec 31, 2023 | 1.89B | 732.07M | 63.50% |
| Dec 31, 2022 | 1.15B | -233.18M | -16.82% |
| Dec 31, 2021 | 1.39B | 746.83M | 116.82% |
| Dec 31, 2020 | 639.29M | -757.91M | -54.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.50T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.50T |
| SK Biopharmaceuticals | 620.28B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |
| LigaChem Biosciences | 148.28B |